五洲医疗：周乐翔、潘岚岚完成减持

Core Viewpoint - The announcement indicates that shareholders Zhou Lexiang and Pan Lanlan have completed their share reduction plans as of December 15, 2025, impacting the company's total shareholding structure [1] Shareholder Actions - Zhou Lexiang reduced his holdings by 127,500 shares, representing 0.1875% of the company's total share capital, with a reduction price range of 38.2 to 45.5 yuan per share [1] - Pan Lanlan reduced her holdings by 69,050 shares, representing 0.1015% of the company's total share capital, with the same price range of 38.2 to 45.5 yuan per share [1] Post-Reduction Holdings - After the reduction, Zhou Lexiang holds 382,500 shares, which is 0.5625% of the company's total share capital [1] - After the reduction, Pan Lanlan holds 207,100 shares, which is 0.3046% of the company's total share capital [1]